Predict your next investment

MC10 company logo
INDUSTRIAL | Basic Materials / Synthetics
mc10inc.com

See what CB Insights has to offer

Founded Year

2008

Stage

Convertible Note - III | Alive

Total Raised

$101.78M

Last Raised

$2.47M | 2 yrs ago

About MC10

MC10 is developing electronic systems through its Conformal Electronics Platform. The platform enhances and enables applications by allowing electronics to occupy spaces and geometries not possible in traditional, rigid form. Backed by a patent portfolio secured both through in-licensing and continued developments at MC10, the company is targeting applications in consumer electronics, medical devices, industrial products, and defense systems.

MC10 Headquarter Location

10 Maguire Road Building 3, 1st Floor

Cambridge, Massachusetts, 02141,

United States

857-214-5600

Latest MC10 News

Medidata Acquires Digital Biomarker Business of MC10, Enhancing Remote Biometric Data Capture Capabilities in Hybrid and Virtual Clinical Trials

Oct 27, 2020

October 27, 2020 09:00 AM Eastern Daylight Time NEW YORK--( BUSINESS WIRE )--Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutions to support the entire clinical development process, acquired the digital biomarker business of MC10. MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing Patient Cloud solutions in ePRO (patient-reported outcomes), eCOA (clinical outcome assessments), and biomarker discovery. This will enhance Medidata’s capabilities of integrating data from wearable sensors – including clinical grade metrics – to help customers successfully virtualize clinical trials. Remote, patient-centered technologies have become an essential part of clinical research, especially in the age of COVID-19; the physical restrictions placed on patients and clinical sites caused by the pandemic can interfere with launching a clinical study and carrying it to completion. Wearable sensors are used in about 15 percent of studies, and the use of sensors is expected to grow to approximately 70 percent by 2025. * Medidata leads the industry in building and integrating new technologies to revolutionize clinical research in pursuit of patient-centric therapy development. MC10’s focus on clinical grade data capture and novel digital biomarker development represent an important next chapter – advancing the understanding of disease progression and treatment effect in the home. “Medidata is excited to add the pioneering work at MC10 to our ongoing efforts in building a new platform for ingestion and analytics across a wide array of mobile sensors,” said Anthony Costello, senior vice president, Mobile Health, Medidata. “Incorporating remote biometric data capture and analysis that includes the MC10 nPoint Biostamp, alongside other leading mobile devices, will further strengthen the Medidata platform and help propel the digital transformation of life sciences.” An integrated Medidata offering will provide research companies and device developers new and innovative ways to collect, normalize and analyze data in pursuit of new therapy development. This enhanced capability will also create a closer connection between patients and the ecosystem of trailblazing researchers, practitioners, and life science companies committed to deepening a shared understanding of disease, transformational therapies, and novel endpoints. “Medidata is an exceptional fit for MC10. Our combined expertise will help customers and partners take a more data-driven approach to bringing targeted therapies to patients,” said Ben Schlatka, co-founder and CEO, MC10. “We are looking forward to moving ahead together, accelerating the development and deployment of new innovative offerings for our customers and ultimately transforming therapy development to improve the lives of patients.” Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization. *Intel, “AI and Wearables Bring New Data and Analytics to Clinical Trials,” 2017. About Medidata Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,600+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata , The Operating System for Life SciencesTM. About Dassault Systèmes Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual experience twins of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production. Dassault Systèmes brings value to more than 270,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com . 3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, EXALEAD, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systèmes, a French “société européenne” (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries. About MC10 MC10 is a privately held company focused on improving human health through digital solutions. The company combines conformal BioStamp sensors with clinical analytics to unlock novel insights from physiological data collected from the home or in clinical settings. Our flagship product, BioStamp nPoint, is intended for the clinical research community. MC10 is headquartered in Lexington, MA. Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing MC10

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned MC10 in 1 CB Insights research brief, most recently on Mar 12, 2020.

Expert Collections containing MC10

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MC10 is included in 12 Expert Collections, including Wearable Computing.

W

Wearable Computing

379 items

Wearable computing is broadly defined as companies developing devices worn or placed on the body that are equipped with technology, which can range from wearable medical devices to AR/VR headsets to GPS pet collars.

C

Clinical Trials Tech

318 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

I

Internet of Things ( IoT )

3,149 items

A

Advanced Materials

1,229 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

A

Artificial Intelligence

8,321 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

11,221 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

MC10 Patents

MC10 has filed 110 patents.

The 3 most popular patent topics include:

  • Sensors
  • Semiconductor device fabrication
  • Computer memory
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/19/2017

10/26/2021

Mass spectrometry, Home automation, Ion source, Internet of things, Skin anatomy

Grant

Application Date

4/19/2017

Grant Date

10/26/2021

Title

Related Topics

Mass spectrometry, Home automation, Ion source, Internet of things, Skin anatomy

Status

Grant

MC10 Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

MC10 Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.